Vitamin D deficiency aggravates ischemic acute kidney injury in rats
Carregando...
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
PHYSIOLOGICAL REPORTS, v.3, n.3, article ID e12331, 13p, 2015
Resumo
Vitamin D deficiency (VDD) increases the risk of death in hospitalized patients. Renal ischemia/reperfusion injury (IRI) induces acute kidney injury (AKI), which activates cell cycle inhibitors, including p21, a cyclindependent kinase inhibitor and genomic target of 25-hydroxyvitamin D, which is in turn a potent immunomodulator with antiproliferative effects. In this study, we assess the impact of VDD in renal IRI. Wistar rats were divided into groups, each evaluated for 30 days: control (receiving a standard diet); VDD (receiving a vitamin D-free diet); IRI (receiving a standard diet and subjected to 45-min bilateral renal ischemia on day 28); and VDD + IRI (receiving a vitamin D-free diet and subjected to 45-min bilateral renal ischemia on day 28). At 48 h after IRI, animals were euthanized; blood, urine, and kidney tissue samples were collected. Compared with IRI rats, VDD + IRI rats showed a more severe decrease in glomerular filtration rate, greater urinary protein excretion, a higher kidney/body weight ratio and lower renal aquaporin 2 expression, as well as greater morphological damage, characterized by increased interstitial area and tubular necrosis. Our results suggest that the severity of tubular damage in IRI may be associated with downregulation of vitamin D receptors and p21. VDD increases renal inflammation, cell proliferation and cell injury in ischemic AKI.
Palavras-chave
Acute kidney injury, vitamin D deficiency, vitamin D receptors, cyclin-dependent kinase inhibitor p21
Referências
- Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041
- Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738
- Braun Andrea B., 2013, Inflammation & Allergy Drug Targets, V12, P262
- Braun AB, 2012, CRIT CARE MED, V40, P3170, DOI 10.1097/CCM.0b013e318260c928
- BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
- de Araujo M, 2005, J AM SOC NEPHROL, V16, P3339, DOI 10.1681/2004100832
- de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015
- de Boer IH, 2011, CLIN J AM SOC NEPHRO, V6, P2141, DOI 10.2215/CJN.02640311
- Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004
- Evans RG, 2013, CLIN EXP PHARMACOL P, V40, P106, DOI 10.1111/1440-1681.12031
- Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408
- Hewison M, 2000, J MOL ENDOCRINOL, V25, P141, DOI 10.1677/jme.0.0250141
- Holick MF, 2013, ANTI-CANCER AGENT ME, V13, P70
- Hussein AAM, 2012, ACTA PHYSIOL, V204, P308, DOI 10.1111/j.1748-1716.2011.02372.x
- Kuhlmann A, 2004, AM J PHYSIOL-RENAL, V286, pF526, DOI 10.1152/ajprenal.00316.2003
- Lancas T, 2011, RESPIRATION, V82, P177, DOI 10.1159/000326897
- Lee DR, 2011, TRANSPL P, V43, P3723, DOI 10.1016/j.transproceed.2011.08.081
- Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996
- Leonard EC, 2008, AM J PHYSIOL-RENAL, V295, pF1648, DOI 10.1152/ajprenal.00099.2008
- Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142
- Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
- Lucisano S, 2013, KIDNEY BLOOD PRESS R, V37, P667, DOI 10.1159/000355747
- Megyesi J, 1996, AM J PHYSIOL-RENAL, V271, pF1211
- Megyesi J, 2001, KIDNEY INT, V60, P2164, DOI 10.1046/j.1523-1755.2001.00044.x
- Metra M, 2012, EUR HEART J, V33, P2135, DOI 10.1093/eurheartj/ehs205
- Miyaji T, 2001, J AM SOC NEPHROL, V12, P900
- Osborne JE, 2002, BRIT J DERMATOL, V147, P197, DOI 10.1046/j.1365-2133.2002.04960.x
- Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200
- Powers JG, 2012, SEMIN CUTAN MED SURG, V31, P2, DOI [10.1016/j.sder.2011.12.001, 10.1016/j.sder.2011.11.008]
- Price PM, 2009, KIDNEY INT, V76, P604, DOI 10.1038/ki.2009.224
- Price PM, 2003, SEMIN NEPHROL, V23, P449, DOI 10.1016/S0270-9295(03)00087-1
- Schenk LK, 2012, CRIT CARE MED, V40, P3314, DOI 10.1097/CCM.0b013e3182632b2c
- Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b
- Taniguchi M, 2006, KIDNEY INT, V69, P464, DOI 10.1038/sj.ki.5000090
- Tokumoto M, 2002, KIDNEY INT, V62, P1196, DOI 10.1046/j.1523-1755.2002.00585.x
- Vaidya A, 2012, METABOLISM, V61, P450, DOI 10.1016/j.metabol.2011.09.007
- Valrance ME, 2004, J STEROID BIOCHEM, V89-90, P221, DOI 10.1016/j.jsbmb.2004.03.082
- Zehnder D, 1999, MOL CELL ENDOCRINOL, V151, P213, DOI 10.1016/S0303-7207(99)00039-8
- Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872